相关实验视频

Updated: May 6, 2026

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Published on: April 26, 2016

用carboplatin优化淋巴药物输送系统,用于转移性淋巴结

Miriu Miyatsu¹, Ariunbuyan Sukhbaatar^1,2,3, Radhika Mishra¹

¹Laboratory of Biomedical Engineering for Cancer, Graduate School of Biomedical Engineering, Tohoku University, 4‑1 Seiryo, Aoba, Sendai, Miyagi, 980‑8575, Japan.

Scientific reports

|May 9, 2025

概括

优化淋巴药物递送系统 (LDDS) 具有特定的透压力,粘度和注射速率可以提高淋巴结 (LNs) 中的药物保留,用于长期的癌症治疗. 这种方法提高了对转移性淋巴结的治疗疗效.

科学领域:

在瘤学瘤学.
纳米医学是一种纳米医学.
药理学药理学是指药理学的学科.

背景情况:

转移性淋巴结 (LNs) 的全身化疗具有较低的组织选择性和高毒性.
淋巴淋巴药物递送系统 (LDDS) 提供了一种针对和治疗LN转移的新方法.
以前的研究表明,增加的透压和粘度会增加LNs中的药物保留.

研究的目的:

优化淋巴淋巴药物递送系统 (LDDS) 的给药条件,以实现转移性淋巴结的长期治疗反应.
研究不同剂量,注射速率,透压和粘度对药物保留和疗效的影响.

主要方法:

通过使用MXH10/Mo/lpr小鼠建立了一个转移性LN小鼠模型,用光酶标记的FM3A细胞接种在 subiliac LN (SiLN).
碳白 (CBDCA) 通过LDDS在不同的条件下 (剂量,注射速率,透压,粘度) 通过LDDS给载瘤的SiLN.
监测了LNs中的药物保留,并分析了中的免疫反应 (CD8,IL-12a,IFN-γ).

主要成果:

在注射速率为10μL/分钟的情况下,使用双剂量CBDCA溶液,透压为1897 kPa,粘度为12 mPa·s,导致药物保持率更高.
这种增强的药物保留持续了42天.
在脏中观察到CD8,IL-12a和IFN-γ的高调表达,这表明免疫反应.

结论:

优化的LDDS参数,特别是10μL/分钟的双剂量给药,具有超透性和高粘度配方,对淋巴结中的长期药物保留有效.
这种优化的LDDS方法显著提高了对淋巴结转移的治疗疗效.
这些发现表明,增强转移性淋巴结癌症治疗的有希望的策略.

关键词:

碳烯金是碳烯金中的一种.化疗化疗是一种化学疗法.淋巴结转移是淋巴结的转移.淋巴体药物输送系统是淋巴体药物输送系统.奥斯莫斯压力和粘度的奥斯莫斯压力和粘度

更多相关视频

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice

Published on: October 5, 2017

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

相关概念视频

Modified-Release Drug Delivery Systems: Site-Targeted

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...